Extent of ST-segment depression and cardiac events in non-ST-segment elevation acute coronary syndromes

Stefano Savonitto, Mauricio G Cohen, Alessandro Politi, Michael P. Hudson, David F. Kong, Yao Huang, Karen S. Pieper, Francesco Mauri, Galen S. Wagner, Robert M. Califf, Eric J. Topol, Christopher B. Granger

Research output: Contribution to journalArticle

50 Citations (Scopus)

Abstract

Aims: We sought to determine whether the extent of myocardial ischaemia on the admission electrocardiogram (ECG) has independent predictive value for short-term risk stratification of patients with non-ST-segment elevation acute coronary syndromes (NSTE ACS). Although the presence of ischaemic ECG changes on admission has been shown to predict outcome, the relationship between the extent of ECG changes and the risk of cardiac events is still ill defined. Methods and results: We analysed the admission ECGs of 5192 ACS patients enrolled in the GUSTO-IIb trial, without an ECG indication for thrombolysis. ECG tracings showing one or more of the following were eligible: ST-segment depression >0.5 mm, T-wave inversion >1 mm, and ST-segment elevation >0.5 mm but <1 mm. ECG variables associated with unfavourable 30 day outcomes in a univariable analysis were further assessed in a multivariable logistic regression model including independent clinical predictors. In the multivariable clinical, enzymatic, and ECG model, the sum of ST-segment depression (in millimetres) in all leads was a powerful independent predictor of 30 day death (P < 0.0001), with a continuous increase in risk with the extent of ST-segment depression. The sum of ST-segment depression (P < 0.0001) and the presence of minimal inferior ST-segment elevation (P < 0.0001) or anterior ST-segment elevation (P = 0.0182) were also independent predictors of the composite of death and myocardial infarction or reinfarction. The extent of ST-segment depression showed a highly significant correlation with the prevalence of three-vessel (P < 0.0001) or left main coronary disease (P < 0.0001), and also with the peak levels of creatine kinase (P < 0.0001) during the index episode of ACS. Conclusion: In patients with NSTE ACS, the sum of ST-segment depression in all ECG leads is a powerful predictor of all-cause mortality at 30 days, independent of clinical variables and correlates with the extent and severity of coronary artery disease. The presence of even minimal (<1 mm) ST-segment elevation in anterior or inferior leads is independently associated with adverse outcomes.

Original languageEnglish
Pages (from-to)2106-2113
Number of pages8
JournalEuropean Heart Journal
Volume26
Issue number20
DOIs
StatePublished - Oct 1 2005
Externally publishedYes

Fingerprint

Acute Coronary Syndrome
Electrocardiography
Logistic Models
Creatine Kinase
Myocardial Ischemia
Coronary Disease
Coronary Artery Disease
Myocardial Infarction
Mortality

Keywords

  • Electrocardiogram
  • Logistic regression analysis
  • Myocardial infarction
  • Non-ST-segment elevation acute coronary syndromes
  • Prognosis

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Cite this

Extent of ST-segment depression and cardiac events in non-ST-segment elevation acute coronary syndromes. / Savonitto, Stefano; Cohen, Mauricio G; Politi, Alessandro; Hudson, Michael P.; Kong, David F.; Huang, Yao; Pieper, Karen S.; Mauri, Francesco; Wagner, Galen S.; Califf, Robert M.; Topol, Eric J.; Granger, Christopher B.

In: European Heart Journal, Vol. 26, No. 20, 01.10.2005, p. 2106-2113.

Research output: Contribution to journalArticle

Savonitto, S, Cohen, MG, Politi, A, Hudson, MP, Kong, DF, Huang, Y, Pieper, KS, Mauri, F, Wagner, GS, Califf, RM, Topol, EJ & Granger, CB 2005, 'Extent of ST-segment depression and cardiac events in non-ST-segment elevation acute coronary syndromes', European Heart Journal, vol. 26, no. 20, pp. 2106-2113. https://doi.org/10.1093/eurheartj/ehi395
Savonitto, Stefano ; Cohen, Mauricio G ; Politi, Alessandro ; Hudson, Michael P. ; Kong, David F. ; Huang, Yao ; Pieper, Karen S. ; Mauri, Francesco ; Wagner, Galen S. ; Califf, Robert M. ; Topol, Eric J. ; Granger, Christopher B. / Extent of ST-segment depression and cardiac events in non-ST-segment elevation acute coronary syndromes. In: European Heart Journal. 2005 ; Vol. 26, No. 20. pp. 2106-2113.
@article{bde229b060824fa3a817f6ca1d4ffadb,
title = "Extent of ST-segment depression and cardiac events in non-ST-segment elevation acute coronary syndromes",
abstract = "Aims: We sought to determine whether the extent of myocardial ischaemia on the admission electrocardiogram (ECG) has independent predictive value for short-term risk stratification of patients with non-ST-segment elevation acute coronary syndromes (NSTE ACS). Although the presence of ischaemic ECG changes on admission has been shown to predict outcome, the relationship between the extent of ECG changes and the risk of cardiac events is still ill defined. Methods and results: We analysed the admission ECGs of 5192 ACS patients enrolled in the GUSTO-IIb trial, without an ECG indication for thrombolysis. ECG tracings showing one or more of the following were eligible: ST-segment depression >0.5 mm, T-wave inversion >1 mm, and ST-segment elevation >0.5 mm but <1 mm. ECG variables associated with unfavourable 30 day outcomes in a univariable analysis were further assessed in a multivariable logistic regression model including independent clinical predictors. In the multivariable clinical, enzymatic, and ECG model, the sum of ST-segment depression (in millimetres) in all leads was a powerful independent predictor of 30 day death (P < 0.0001), with a continuous increase in risk with the extent of ST-segment depression. The sum of ST-segment depression (P < 0.0001) and the presence of minimal inferior ST-segment elevation (P < 0.0001) or anterior ST-segment elevation (P = 0.0182) were also independent predictors of the composite of death and myocardial infarction or reinfarction. The extent of ST-segment depression showed a highly significant correlation with the prevalence of three-vessel (P < 0.0001) or left main coronary disease (P < 0.0001), and also with the peak levels of creatine kinase (P < 0.0001) during the index episode of ACS. Conclusion: In patients with NSTE ACS, the sum of ST-segment depression in all ECG leads is a powerful predictor of all-cause mortality at 30 days, independent of clinical variables and correlates with the extent and severity of coronary artery disease. The presence of even minimal (<1 mm) ST-segment elevation in anterior or inferior leads is independently associated with adverse outcomes.",
keywords = "Electrocardiogram, Logistic regression analysis, Myocardial infarction, Non-ST-segment elevation acute coronary syndromes, Prognosis",
author = "Stefano Savonitto and Cohen, {Mauricio G} and Alessandro Politi and Hudson, {Michael P.} and Kong, {David F.} and Yao Huang and Pieper, {Karen S.} and Francesco Mauri and Wagner, {Galen S.} and Califf, {Robert M.} and Topol, {Eric J.} and Granger, {Christopher B.}",
year = "2005",
month = "10",
day = "1",
doi = "10.1093/eurheartj/ehi395",
language = "English",
volume = "26",
pages = "2106--2113",
journal = "European Heart Journal",
issn = "0195-668X",
publisher = "Oxford University Press",
number = "20",

}

TY - JOUR

T1 - Extent of ST-segment depression and cardiac events in non-ST-segment elevation acute coronary syndromes

AU - Savonitto, Stefano

AU - Cohen, Mauricio G

AU - Politi, Alessandro

AU - Hudson, Michael P.

AU - Kong, David F.

AU - Huang, Yao

AU - Pieper, Karen S.

AU - Mauri, Francesco

AU - Wagner, Galen S.

AU - Califf, Robert M.

AU - Topol, Eric J.

AU - Granger, Christopher B.

PY - 2005/10/1

Y1 - 2005/10/1

N2 - Aims: We sought to determine whether the extent of myocardial ischaemia on the admission electrocardiogram (ECG) has independent predictive value for short-term risk stratification of patients with non-ST-segment elevation acute coronary syndromes (NSTE ACS). Although the presence of ischaemic ECG changes on admission has been shown to predict outcome, the relationship between the extent of ECG changes and the risk of cardiac events is still ill defined. Methods and results: We analysed the admission ECGs of 5192 ACS patients enrolled in the GUSTO-IIb trial, without an ECG indication for thrombolysis. ECG tracings showing one or more of the following were eligible: ST-segment depression >0.5 mm, T-wave inversion >1 mm, and ST-segment elevation >0.5 mm but <1 mm. ECG variables associated with unfavourable 30 day outcomes in a univariable analysis were further assessed in a multivariable logistic regression model including independent clinical predictors. In the multivariable clinical, enzymatic, and ECG model, the sum of ST-segment depression (in millimetres) in all leads was a powerful independent predictor of 30 day death (P < 0.0001), with a continuous increase in risk with the extent of ST-segment depression. The sum of ST-segment depression (P < 0.0001) and the presence of minimal inferior ST-segment elevation (P < 0.0001) or anterior ST-segment elevation (P = 0.0182) were also independent predictors of the composite of death and myocardial infarction or reinfarction. The extent of ST-segment depression showed a highly significant correlation with the prevalence of three-vessel (P < 0.0001) or left main coronary disease (P < 0.0001), and also with the peak levels of creatine kinase (P < 0.0001) during the index episode of ACS. Conclusion: In patients with NSTE ACS, the sum of ST-segment depression in all ECG leads is a powerful predictor of all-cause mortality at 30 days, independent of clinical variables and correlates with the extent and severity of coronary artery disease. The presence of even minimal (<1 mm) ST-segment elevation in anterior or inferior leads is independently associated with adverse outcomes.

AB - Aims: We sought to determine whether the extent of myocardial ischaemia on the admission electrocardiogram (ECG) has independent predictive value for short-term risk stratification of patients with non-ST-segment elevation acute coronary syndromes (NSTE ACS). Although the presence of ischaemic ECG changes on admission has been shown to predict outcome, the relationship between the extent of ECG changes and the risk of cardiac events is still ill defined. Methods and results: We analysed the admission ECGs of 5192 ACS patients enrolled in the GUSTO-IIb trial, without an ECG indication for thrombolysis. ECG tracings showing one or more of the following were eligible: ST-segment depression >0.5 mm, T-wave inversion >1 mm, and ST-segment elevation >0.5 mm but <1 mm. ECG variables associated with unfavourable 30 day outcomes in a univariable analysis were further assessed in a multivariable logistic regression model including independent clinical predictors. In the multivariable clinical, enzymatic, and ECG model, the sum of ST-segment depression (in millimetres) in all leads was a powerful independent predictor of 30 day death (P < 0.0001), with a continuous increase in risk with the extent of ST-segment depression. The sum of ST-segment depression (P < 0.0001) and the presence of minimal inferior ST-segment elevation (P < 0.0001) or anterior ST-segment elevation (P = 0.0182) were also independent predictors of the composite of death and myocardial infarction or reinfarction. The extent of ST-segment depression showed a highly significant correlation with the prevalence of three-vessel (P < 0.0001) or left main coronary disease (P < 0.0001), and also with the peak levels of creatine kinase (P < 0.0001) during the index episode of ACS. Conclusion: In patients with NSTE ACS, the sum of ST-segment depression in all ECG leads is a powerful predictor of all-cause mortality at 30 days, independent of clinical variables and correlates with the extent and severity of coronary artery disease. The presence of even minimal (<1 mm) ST-segment elevation in anterior or inferior leads is independently associated with adverse outcomes.

KW - Electrocardiogram

KW - Logistic regression analysis

KW - Myocardial infarction

KW - Non-ST-segment elevation acute coronary syndromes

KW - Prognosis

UR - http://www.scopus.com/inward/record.url?scp=26044462168&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=26044462168&partnerID=8YFLogxK

U2 - 10.1093/eurheartj/ehi395

DO - 10.1093/eurheartj/ehi395

M3 - Article

C2 - 15987706

AN - SCOPUS:26044462168

VL - 26

SP - 2106

EP - 2113

JO - European Heart Journal

JF - European Heart Journal

SN - 0195-668X

IS - 20

ER -